Tenet Healthcare (NYSE:THC) Shareholders Have Earned a 28% CAGR Over the Last Five Years
Tenet Healthcare (NYSE:THC) Shareholders Have Earned a 28% CAGR Over the Last Five Years
While Tenet Healthcare Corporation (NYSE:THC) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 19% in the last quarter. But that doesn't change the fact that shareholders have received really good returns over the last five years. It's fair to say most would be happy with 248% the gain in that time. We think it's more important to dwell on the long term returns than the short term returns. Ultimately business performance will determine whether the stock price continues the positive long term trend.
儘管泰尼特(NYSE:THC)股東可能普遍感到滿意,但該股票最近的表現並不理想,股價在上個季度下跌了19%。但這並沒有改變股東在過去五年中獲得非常好回報的事實。可以公平地說,絕大多數人會對這段時間的248%的收益感到滿意。我們認爲,關注長期回報比短期回報更爲重要。最終,業務表現將判斷股價是否繼續保持積極的長期趨勢。
Now it's worth having a look at the company's fundamentals too, because that will help us determine if the long term shareholder return has matched the performance of the underlying business.
現在值得關注一下公司的基本面,因爲這將幫助我們判斷長期股東回報是否與基礎業務的表現相匹配。
To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.
借用本傑明·格雷厄姆的話來說:短期內市場是一個投票機,但長期來說它是一個稱重機。一種存在缺陷但合理的評估公司情緒變化的方法是將每股收益(EPS)與股價進行比較。
During the five years of share price growth, Tenet Healthcare moved from a loss to profitability. That kind of transition can be an inflection point that justifies a strong share price gain, just as we have seen here. Given that the company made a profit three years ago, but not five years ago, it is worth looking at the share price returns over the last three years, too. We can see that the Tenet Healthcare share price is up 63% in the last three years. In the same period, EPS is up 48% per year. This EPS growth is higher than the 18% average annual increase in the share price over the same three years. So you might conclude the market is a little more cautious about the stock, these days. This unenthusiastic sentiment is reflected in the stock's reasonably modest P/E ratio of 3.84.
在過去五年的股價增長中,泰尼特從虧損轉變爲盈利。這種轉變可能是一個突破點,正如我們在這裏看到的,證明了強勁的股價上漲。考慮到公司在三年前盈利,但五年前卻不盈利,因此還值得看看過去三年的股價回報。我們可以看到,泰尼特股價在過去三年中上漲了63%。在同一時期,每股收益增長了48%每年。這一每股收益的增長高於同三年股價平均年增長的18%。所以你可能會得出結論,市場對這隻股票目前有些謹慎。這種不太熱情的情緒反映在該股相對溫和的市盈率3.84上。
You can see below how EPS has changed over time (discover the exact values by clicking on the image).
您可以在下面看到EPS如何隨時間變化(點擊圖片可以發現具體數值)。
We know that Tenet Healthcare has improved its bottom line over the last three years, but what does the future have in store? If you are thinking of buying or selling Tenet Healthcare stock, you should check out this FREE detailed report on its balance sheet.
我們知道泰尼特在過去三年間改善了其底線,但未來會怎樣呢?如果您考慮買入或賣出泰尼特股票,您應該查看這份關於其資產負債表的免費詳細報告。
A Different Perspective
不同的視角
It's good to see that Tenet Healthcare has rewarded shareholders with a total shareholder return of 70% in the last twelve months. That's better than the annualised return of 28% over half a decade, implying that the company is doing better recently. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. It's always interesting to track share price performance over the longer term. But to understand Tenet Healthcare better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 4 warning signs with Tenet Healthcare (at least 1 which is significant) , and understanding them should be part of your investment process.
看到泰尼特在過去十二個月中爲股東帶來了70%的總股東回報是件好事。這比過去五年年化回報28%要好,暗示該公司最近的表現更佳。考慮到股價動能依然強勁,可能值得仔細關注這隻股票,以免錯過機會。長期來看,跟蹤股價表現總是很有趣。但要更好地了解泰尼特,我們需要考慮許多其他因素。例如,投資風險的始終存在。我們已經識別出泰尼特的4個警告信號(至少有1個是重要的),理解這些信號應該是您投資過程的一部分。
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.
當然,你可能會通過其他地方尋找一個絕佳的投資機會。所以請查看這個我們預計將增長每股收益的公司免費列表。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.
請注意,本文中引用的市場回報反映了當前在美國交易所上市股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall ST的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall ST在提到的任何股票中均沒有持倉。